# Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure

> **NCT00383630** · PHASE2 · TERMINATED · sponsor: **Columbia University** · enrollment: 1 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **BIOLOGICAL:** Intramyocardial injection of bone marrow mononuclear cells
- **BIOLOGICAL:** Intramyocardial injection of CD34+ selected bone marrow mononuclear cells
- **DEVICE:** LVAD alone

## Key facts

- **NCT ID:** NCT00383630
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Terminated due to logistical barriers to cell processing and poor enrollment
- **Last updated:** 2019-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383630, "Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00383630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*